
LENSAR LNSR
$ 6.05
-0.66%
Quarterly report 2026-Q1
added 05-08-2026
LENSAR Interest Expense 2011-2026 | LNSR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense LENSAR
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 636 K | 660 K | 698 K | 263 K | 51 K | 1.34 M | 2 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2 M | 51 K | 807 K |
Quarterly Interest Expense LENSAR
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145 K | 133 K | 193 K | 159 K | - | 153 K | 160 K | 198 K | - | 265 K | 111 K | 89 K | - | 92 K | 39 K | 9 K | - | 10 K | 13 K | 18 K | - | 65 K | 671 K | 604 K | - | 494 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 671 K | 9 K | 181 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.82 | 3.32 % | $ 335 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 8.06 | -2.54 % | $ 1.21 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.31 | 0.23 % | $ 161 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.3 | 0.44 % | $ 50.7 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.9 | -2.56 % | $ 420 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.83 | -1.72 % | $ 388 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 75.42 | 2.15 % | $ 4.11 B | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.57 | 1.29 % | $ 63.9 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.67 | 1.38 % | $ 542 M | ||
|
Electromed
ELMD
|
455 K | $ 38.3 | 0.21 % | $ 324 M | ||
|
Myomo
MYO
|
-668 K | $ 1.03 | -0.96 % | $ 43.1 M | ||
|
Butterfly Network
BFLY
|
2.77 M | $ 4.54 | 1.68 % | $ 1.12 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 9.77 | -9.12 % | $ 387 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 85.1 | 0.34 % | $ 11.5 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.77 | -0.88 % | $ 205 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 153.8 | -0.69 % | $ 10.8 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.06 | -3.14 % | $ 1.12 B | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.43 | 1.67 % | $ 6.74 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 41.99 | -4.22 % | $ 1.23 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 90.14 | 0.96 % | $ 3.13 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 87.54 | 2.05 % | $ 51.2 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 70.46 | 2.21 % | $ 2.4 B |